A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101

References

Page 1

	Year	Citations
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer K. Kian Ang, Jonathan Harris, Richard Wheeler, New England Journal of Medicine	2010	6.4K
Olaparib for Metastatic Breast Cancer in Patients with a Germline <i>BRCA</i> Mutation Mark E. Robson, Seock‐Ah Im, Elżbieta Senkus, New England Journal of Medicine	2017	3.1K
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients Jean‐Pierre Pignon, Aurélie Le Maître, E. Maillard, Radiotherapy and Oncology Neck CancerMedicineRandomised TrialsClinical TrialsHead And Neck Cancer	2009	3K
Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation Jennifer K. Litton, Hope S. Rugo, Johannes Ettl, New England Journal of Medicine	2018	2K
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer Marshall R. Posner, Diáne Hershock, C. Blajman, New England Journal of Medicine	2007	1.7K
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer Jan B. Vermorken, Éva Remenár, Carla van Herpen, New England Journal of Medicine	2007	1.7K
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial Maura L. Gillison, Andy Trotti, Jonathan Harris, The Lancet Radiation TherapyMedicineNasopharyngeal CancerNon-inferiority TrialCancer Treatment	2018	1.2K
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial Hisham Mehanna, Max Robinson, A. Hartley, The Lancet	2018	988
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer Robert L. Coleman, Gini F. Fleming, Mark F. Brady, New England Journal of Medicine	2019	886
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522 K. Kian Ang, Qiang Zhang, David I. Rosenthal, Journal of Clinical Oncology	2014	821

Page 1